Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes
Source: Critical Care - Category: Intensive Care Authors: Daisuke Hasegawa and Osamu Nishida Tags: Letter Source Type: research
More News: Intensive Care